Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to recieve member pricing. Your ASHP membership number and expiration date are required.
Oncology and Hematology Disorders, the latest release in ACCP’s Pediatric Self-Assessment Program (PedSAP), features comprehensive reviews, timely evidence-based updates, and case series on various topics relating to pediatric oncology treatment and supportive care, and a range of hematological disorders. The target audience for PedSAP 2024 Book 2 (Oncology and Hematology Disorders) is board-certified and advanced-level clinical pharmacists caring for a wide range of pediatric patients with a focus on select oncological and hematological conditions.
Ewig
Oncology and Hematology Disorders carries a total of 21.5 continuing pharmacy education (CPE) credits. Content was developed under the leadership of Faculty Panel Chair Celeste Ewig, Pharm.D., BCPPS, BCPS.
The first module of this book provides an overview of CAR-T cell therapies along with updates in biologics used in various oncological conditions. The second module discusses advances in the application of precision medicine in pediatric oncology and reviews emerging evidence to improve the care of patients undergoing allogenic bone marrow transplant. The third and fourth modules review the management of several hematological disorders along with how newer treatments may be integrated into future practice. The final module contains two case series focusing on supportive care and considerations for vaccination in pediatric oncology patients.
Continuing education activities in PedSAP cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:
- Traditional review-style chapters
- Case-series (major sections of learning content bookended by a sample case and its explained answer)
- Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)
PedSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.
Oncology and Hematology Disorders I |
0217-9999-24-195-H01-P |
4.5 CPE Hours |
Oncology and Hematology Disorders II |
0217-9999-24-196-H01-P |
4.0 CPE Hours |
Oncology and Hematology Disorders III |
0217-9999-24-197-H01-P |
3.5 CPE Hours |
Oncology and Hematology Disorders IV |
0217-9999-24-198-H01-P |
5.5 CPE Hours |
Oncology and Hematology Disorders V |
0217-9999-24-199-H01-P |
4.0 CPE Hours |
Release Date: September 16, 2024
BCPPS Deadline: March 17, 2025ACPE Deadline: September 16, 2027
ISBN: 978-1-952291-84-5
Publication Year: 2024
Format: PDF and ePub
Number of Pages: 276